To this end, we obtained an Hb-egf null cancer cell line from an Hb-egf mutant RT2-derived tumor and implanted it orthotopically in the pancreas of 8 syngeneic wild-type mice or 8 Hb-egf mutant mice (see schematic in Fig. 8C). This evidence concerns the gene GSTM1 and neoplasm.